These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37802621)
21. Association between ethnic background and COVID-19 morbidity, mortality and vaccination in England: a multistate cohort analysis using the UK Biobank. Urdiales T; Dernie F; Català M; Prats-Uribe A; Prats C; Prieto-Alhambra D BMJ Open; 2023 Sep; 13(9):e074367. PubMed ID: 37734898 [TBL] [Abstract][Full Text] [Related]
22. The Impact of Priority Settings at the Start of COVID-19 Mass Vaccination on Subsequent Vaccine Uptake in Japan: One-Year Prospective Cohort Study. Hori D; Takahashi T; Ozaki A; Tabuchi T JMIR Public Health Surveill; 2023 Jul; 9():e42143. PubMed ID: 37235691 [TBL] [Abstract][Full Text] [Related]
24. Implementing behavioural science informed letter interventions to increase COVID-19 vaccination uptake in uncontactable London residents: a difference-in-difference study in London, UK. Huf SW; Woldmann L; Crespo RF; Grailey K; Hassanpourfard B; Chisambi M; Black K; Nguyen J; Klaber B; Darzi A Lancet; 2022 Nov; 400 Suppl 1():S41. PubMed ID: 36929986 [TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
26. Reaching Diverse Communities During a Local Public Health COVID-19 Vaccination Response Through a Mobile Clinic Compared to Mass Vaccination Sites. Gavin RM; Countryman M; Musco J; Ricard R; Roberts A; Lees C J Public Health Manag Pract; 2024 May-Jun 01; 30(3):411-415. PubMed ID: 38603747 [TBL] [Abstract][Full Text] [Related]
27. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Voysey M; Costa Clemens SA; Madhi SA; Weckx LY; Folegatti PM; Aley PK; Angus B; Baillie VL; Barnabas SL; Bhorat QE; Bibi S; Briner C; Cicconi P; Clutterbuck EA; Collins AM; Cutland CL; Darton TC; Dheda K; Dold C; Duncan CJA; Emary KRW; Ewer KJ; Flaxman A; Fairlie L; Faust SN; Feng S; Ferreira DM; Finn A; Galiza E; Goodman AL; Green CM; Green CA; Greenland M; Hill C; Hill HC; Hirsch I; Izu A; Jenkin D; Joe CCD; Kerridge S; Koen A; Kwatra G; Lazarus R; Libri V; Lillie PJ; Marchevsky NG; Marshall RP; Mendes AVA; Milan EP; Minassian AM; McGregor A; Mujadidi YF; Nana A; Padayachee SD; Phillips DJ; Pittella A; Plested E; Pollock KM; Ramasamy MN; Ritchie AJ; Robinson H; Schwarzbold AV; Smith A; Song R; Snape MD; Sprinz E; Sutherland RK; Thomson EC; Török ME; Toshner M; Turner DPJ; Vekemans J; Villafana TL; White T; Williams CJ; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ; Lancet; 2021 Mar; 397(10277):881-891. PubMed ID: 33617777 [TBL] [Abstract][Full Text] [Related]
28. Mobile vaccination units substantially increase COVID-19 vaccinations: evidence from a randomized controlled trial. Kulle AC; Schumacher S; von Bieberstein F J Public Health (Oxf); 2024 Feb; 46(1):151-157. PubMed ID: 37986235 [TBL] [Abstract][Full Text] [Related]
29. Understanding the spatial heterogeneity of COVID-19 vaccination uptake in England. Chen H; Cao Y; Feng L; Zhao Q; Torres JRV BMC Public Health; 2023 May; 23(1):895. PubMed ID: 37189026 [TBL] [Abstract][Full Text] [Related]
30. Exploring public sentiment and vaccination uptake of COVID-19 vaccines in England: a spatiotemporal and sociodemographic analysis of Twitter data. Cheng T; Han B; Liu Y Front Public Health; 2023; 11():1193750. PubMed ID: 37663835 [TBL] [Abstract][Full Text] [Related]
31. Dimensions of equality in uptake of COVID-19 vaccination in Wales, UK: A multivariable linked data population analysis. Jones G; Perry M; Bailey R; Arumugam S; Edwards A; Lench A; Cooper A; Akbari A; Collins B; Harris C; Richardson G; Barry M; Harris P; Fry R; Lyons RA; Cottrell S Vaccine; 2023 Nov; 41(49):7333-7341. PubMed ID: 37932133 [TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial. Li G; Cappuccini F; Marchevsky NG; Aley PK; Aley R; Anslow R; Bibi S; Cathie K; Clutterbuck E; Faust SN; Feng S; Heath PT; Kerridge S; Lelliott A; Mujadidi Y; Ng KF; Rhead S; Roberts H; Robinson H; Roderick MR; Singh N; Smith D; Snape MD; Song R; Tang K; Yao A; Liu X; Lambe T; Pollard AJ; Lancet; 2022 Jun; 399(10342):2212-2225. PubMed ID: 35691324 [TBL] [Abstract][Full Text] [Related]
33. National surveillance data analysis of COVID-19 vaccine uptake in England by women of reproductive age. Magee LA; Molteni E; Bowyer V; Bone JN; Boulding H; Khalil A; Mistry HD; Poston L; Silverio SA; Wolfe I; Duncan EL; von Dadelszen P; Nat Commun; 2023 Feb; 14(1):956. PubMed ID: 36813760 [TBL] [Abstract][Full Text] [Related]
34. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study. Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185 [TBL] [Abstract][Full Text] [Related]
35. The UPTAKE study: a cross-sectional survey examining the insights and beliefs of the UK population on COVID-19 vaccine uptake and hesitancy. Sethi S; Kumar A; Mandal A; Shaikh M; Hall CA; Kirk JMW; Moss P; Brookes MJ; Basu S BMJ Open; 2021 Jun; 11(6):e048856. PubMed ID: 34130964 [TBL] [Abstract][Full Text] [Related]
36. Effect of Text Messaging and Behavioral Interventions on COVID-19 Vaccination Uptake: A Randomized Clinical Trial. Mehta SJ; Mallozzi C; Shaw PA; Reitz C; McDonald C; Vandertuyn M; Balachandran M; Kopinsky M; Sevinc C; Johnson A; Ward R; Park SH; Snider CK; Rosin R; Asch DA JAMA Netw Open; 2022 Jun; 5(6):e2216649. PubMed ID: 35696165 [TBL] [Abstract][Full Text] [Related]
37. The effect of a proof-of-vaccination requirement, incentive payments, and employer-based mandates on COVID-19 vaccination rates in New York City: a synthetic-control analysis. Cohn E; Chimowitz M; Long T; Varma JK; Chokshi DA Lancet Public Health; 2022 Sep; 7(9):e754-e762. PubMed ID: 36057274 [TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
39. COVID-19 vaccination uptake in 441 socially and ethnically diverse pregnant women. Husain F; Powys VR; White E; Jones R; Goldsmith LP; Heath PT; Oakeshott P; Razai MS PLoS One; 2022; 17(8):e0271834. PubMed ID: 35976810 [TBL] [Abstract][Full Text] [Related]
40. Measuring inequalities in COVID-19 vaccination uptake and intent: results from the Canadian Community Health Survey 2021. Guay M; Maquiling A; Chen R; Lavergne V; Baysac DJ; Racine A; Dubé E; MacDonald SE; Gilbert NL BMC Public Health; 2022 Sep; 22(1):1708. PubMed ID: 36076208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]